<sub id="jpdrn"><listing id="jpdrn"><form id="jpdrn"></form></listing></sub>

      <pre id="jpdrn"><sub id="jpdrn"><th id="jpdrn"></th></sub></pre>

      <sub id="jpdrn"></sub>

      熱門詞:生物顯微鏡 水質分析儀 微波消解 熒光定量PCR 電化學工作站 生物安全柜

      美國 . Flexcell

      Flexcell? www.flexcellint.com
      Flexcell Intl. Inc. : 細胞拉力. 壓力及剪力仿真培養系統

      世聯博研(北京)科技有限公司(BIO EXCELLENCE INTERNATIONAL Tech Co.,Ltd)

      Our Facility

      Flexcell? is a privately held, for-profit company incorporated in 1987. Flexcell? currently maintains operations in Hillsborough, North Carolina. The facility occupies approximately 10,000 sq. ft. and includes the functions of basic research & development, product engineering, manufacturing, marketing, sales, and warehousing.

      To support these activities, Flexcell? directly employs twelve staff members. Additionally, Flexcell? uses contract labor to supplement specific short term labor needs.



      The History of Flexcell?

      In 1978, Albert J. Banes, Ph.D., an Assistant Professor in the Surgery Department at UNC, received his first small grant for devising a method to apply regulated strain to cultured cells. He built prototypes of the current Flexcell? Tension System in the shop using only a timer, a simple solenoid valve to control pressure in on/off modes, and a needle valve to regulate the magnitude of the pressure. He built a baseplate with vacuum channels in Plexiglas and used natural gum rubber as the seal between the culture plate bottom and the vacuum chamber. Dr. Banes polymerized his own rubber membranes from medical grade Dow silastic components. A cast material that eventually proved satisfactory for the membrane in a 6-well, 35 mm diameter culture plate that has the well bottoms drilled out to receive the cast membranes. The computer industry was still in its infancy. A Commodore Vic 20 was the first commercial microprocessor used to control the valves. The software program and a controller board were designed by Dr. Banes and a well grounded electronics engineer, Olivier Monbureau. A Commodore 64 was the next generation computer used, followed by a Tandy computer, then IBM clones. Today, Flexcell?, under contract, builds its own custom computers and controller boards and assembles them at its plant in Hillsborough, NC.

      Dr. Banes' intellectual property was awarded the first patent in the field of Cytomechanics. He believed that this technology could become important scientifically as well as medically if a market driver could be found. In his first patent describing the technology, he included the thought that cyclically stretching cells and tissues could lead to adaptation of cells to a mechanically active environment such as dermal fibroblasts cultured in vitro in a skin construct. Along with his father in Pennsylvania, G.B. Banes, J.D., they created Flexcell? Inc. The company's mission was to commercialize the technology to make it available to all scientists as well as find medically relevant uses. His first full publication in the area in 1985 in the Journal of Cell Science demonstrated the utility of the system and that cyclic strain altered the expression of cytoplasmic filament proteins such as actin and tubulin in tendon cells.

      Continued development of the technologies behind the Flexcell? Tension and Compression Systems has taken much of Dr. Banes' time. Dr. Banes became the first university professor to be permitted to retain his academic professorship and be president of a company (Flexcell? International Corporation) by a decision of the Committee on Industrial Faculty Relations at the University of North Carolina at Chapel Hill.

      Dr. Banes holds three patents on the basic cell stretching technology and several more on other technologies including a DNA transfection technique using flexation of cells and a spill resistant culture plate called the SpillGuard? culture plate. He continues to develop new products for cell culture and cell stretching as well as submit patents assigned to Flexcell? International Corporation.


      Our Mission


      To be an industry leading developer and manufacturer of biotechnology products for cellular and tissue biomechanics research.

      To provide innovative products and solutions to researchers enabling the advancement of molecular biology and tissue engineering research.

      To be a valued business partner to both our suppliers and distributors and honorable employer to our workforce while maintaining a profitable operation.